Biosimulation for Drug Development
Publisher |
Prateek Joshi
Media Type |
audio
Categories Via RSS |
Technology
Publication Date |
Dec 12, 2023
Episode Duration |
00:32:03

Jo Varshney is the founder and CEO of VeriSIM Life, an AI-driven bio-simulation platform that enables pharmaceutical companies to accelerate drug development. She has a PhD in Comparative Oncology and Genomics.In this episode, we cover a range of topics including: - State of play in AI-powered drug discovery - Why is it so difficult to know which drug candidates to pursue? - The founding of VeriSIM Life - Role of AI in drug formulation - Role of AI in drug repurposing - Role of AI in drug-drug interaction - How does AI help in evaluating potential toxic effects of a drug candidate? - What should ML developers know about biochemistry? And about biochemists? - Determing the efficacy - De Novo drug design - Patient stratification - The future of AI powered drug discovery Jo's favorite book: Built to Last (Author: Jim Collins)--------Where to find Prateek Joshi: Newsletter: https://prateekjoshi.substack.com Website: https://prateekj.com LinkedIn: https://www.linkedin.com/in/prateek-joshi-91047b19 Twitter: https://twitter.com/prateekvjoshi 

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review